day 0, 3, 7, 10, and 14 postwounding ( 18 ) . For immunohistological study, mice were sacrifi ced at day 4 postwounding. Wounds with a 2 mm margin of normal surrounding skin were excised, fi xed in 4% paraformaldehyde (4 h), incubated in 30% sucrose (12 h) , and embedded in OCT. Serial cryosections (10 µm thick/ section) were made, stained with rat anti-mouse CD31 antibody (Santa Cruz Biotech, Santa Cruz, CA) ( 18, 19 ) and then with secondary PE-goat anti-rat IgG (red); nuclei were stained with Hoechst 33342 (blue). The capillary vascular density in the wound bed was determined as CD31+ cells in wound bed/microscope fi eld by examining three fi elds per section of the wound between the edges in six successive sections. The other wound cryosections were stained with hematoxylin-eosin, then analyzed by microscopy ( 18 ) . Sections representing the widest wound beds were chosen to determine granulation tissue area and epithelial gap (distance between leading epithelial edges, measured from wound edges), both of which were measured in pixels. For comparison of different treatments of wounds, capillary vascular density, granulation tissue area, and epithelial gap were presented as relative percentages after normalized to the values of corresponding PBS control. NIH Image J1.40 programs were used for the analysis (NIH, Bethesda, MD) ( 18 ) .
LC-UV-MS/MS analysis of docosanoids
We conducted this analysis in the same manner as in earlier studies ( 6, 23 ) . In brief, we used a liquid chromatography-photodiode array ultra-violet detector-LTQ linear ion trap mass spectrometer (LC-UV-MS/MS) (Thermo, Waltham, MA) equipped with a chiral column (AD-RH, 150 mm × 2.1 mm × 5 m) (Chiral Tech, West Chester, PA) ( 24 ) . Both wideband activation and non-wideband activation were used for MS/MS. The wideband activation excites and fragments ions with mass-to-charge ratio between M and M -20, which generates higher abundance of ions from cleavage of the carbon chain, and provides more structure information of the analytes. The mobile phase fl owed at 0.15 ml/min; it eluted as D (acetonitrile:H 2 O:acetic acid = 45:55:0.01) from 0 to 45 min, ramped to acetonitrile from 45.1 to 60 min, fl owed as acetonitrile for 10 min, and then ran as D again for 10 min. DHA-d 5 (50ng) was used as internal standard, except for the incubations using DHA-d 5 as substrate. Murine skin tissues were extracted with ice-cold acetonitrile three times through homogenization and sonication. Incubations of cells were adjusted to pH 5.5 by adding HCl (1 M) (on ice), and three volumes of icecold acetonitrile were added into each sample (sample: acetonitrile = 1: 3 by volume). Each mixture was vortexed well, then sonicated in water bath (4°C). After centrifugation (3000 rpm, 15 min, 0°C), each pellet was extracted again with three volumes of acetonitrile (pellet: acetonitrile = 1: 3) twice. The supernatants for each sample were pooled together and adjusted to the content of 10% acetonitrile by adding water, and then cleaned up via C18 solid-phase extraction (500 mg, Varian, Palo Alto, CA). The fi nal extracts were reconstituted into acetonitrile for lipidomic analysis.
Enzymatic formation of novel -1-hydroxy docosanoids
14 S ,21-dihydroxy-docosa-4 Z ,7 Z ,10 Z ,12 E ,16 Z ,19 Z -hexaenoic acids (14 S ,21-diHDHAs) were formed as follows. First the intermediate 14 S -hydroxy-DHA (14 S -HDHA) was generated by incubating DHA (50 µg) with porcine leukocyte-12-LOX (L-12-LOX) (1000 unit) (Cayman) in 0.1 M tris buffer (pH 7.4) containing 0.01% Triton-114 (Sigma) (37°C, 20 min) followed by reduction by NaBH 4 .
The incubation was extracted by ethyl acetate three times after its pH was adjusted to 3.5. 14 S -HDHA was isolated from the extract using chiral LC as described above. Additionally 14 S -HDHA wound healing. Some lipid mediators generated by cytochrome P450 (CYP) and 12-lipoxygenase in certain conditions were known to be angiogenic ( 10, 11 ) . Moreover, skin and Mfs are the major source of 12-LOX and P450 (11) (12) (13) (14) (15) (16) . Based on this knowledge, we hypothesized that pro-healing lipid mediators are generated from DHA by 12-LOX-and P450-like catalytic actions in tandem in wounds and Mfs. To test this hypothesis, we conducted a targeted mass spectrometry-based lipidomic study, which is an indispensable approach to unravel the molecular structures and quantities of low-abundant bioactive lipid molecular species during wound healing ( 17 ) . We used the well-accepted splinted excisional wound murine model, where the splints prevent skin contraction and allow wounds to heal through reepithelialization and granulation. Healing of these wounds is accurate and reproducible and closely resembles wound healing in humans (18) (19) (20) . We also studied biosynthesis of novel pro-healing mediators in Mfs. From these studies, we found novel DHAderived -1-hydroxy docosanoids in wounds and Mfs. Moreover, we found that these novel docosanoids promote wound healing and microvasculature formation. Here we report these fi ndings. 
MATERIALS AND METHODS

Reagents
Murine splinted excisional wound healing model
The published protocols were followed (18) (19) (20) , and studies were conducted in blinded fashions and in conformity with the Public Health Service Policy on Humane Care and Use of Laboratory Animals. Animal protocols and all such investigations were approved by the Institutional Animal Care and Use Committee and Institutional Review Board of Louisiana State University Health Sciences Center, New Orleans; and followed the National Institutes of Health guidelines for experimental animal use. Briefl y, under sterile conditions and anesthesia, paired 4-mm circular, full-thickness wounds symmetrically along the midline were made on the dorsal skin of the mice ( ‫ف‬ 22 g body weight, Balb/c, female, 8-10 weeks old). For each of two wounds on a mouse, PBS with specifi c docosanoids (50 ng) was applied to the wound-bed (10 µl) and injected intradermally to 4 points (10 µl/ site) evenly distributed near the wound edge (50 µl total). A donut-shaped 0.5 mm-thick silicone splint was concentric with a wound and fi xed to the skin surrounding the wound with an immediate-bonding adhesive (Krazy Glue ® ) and 6-0 nylon sutures; and then a transparent sterile occlusive dressing then was placed over the wound and the splint ( 20 ) . Mice were fed with a standard chow diet Teklad 2018 containing 0% DHA and 2.76% 3 ␣ -linolenic acid of total fatty acids ( 21 ) . ␣ -linolenic acid can be converted to DHA in rodents ( 22 ) . spectra of three peaks of endogenous 14,21-diHDHAs in wounds, shown in selective ion chromatogram of m/z 271 in MS/MS at m/z 359, have identical ions with similar or different relative abundance. Each spectrum acquired with wideband activation ( Fig. 1A ) -showed another hydroxy at the C 21 position ( Fig. 1A ) . 
Enzymatic formation and pathways of 14 S ,21-diHDHAs and 14 R ,21-diHDHAs
14 S ,21-diHDHAs and 14 R ,21-diHDHAs were investigated for the elucidation of their chemical structures and formation pathways. Incubation of DHA with porcine L-12--LOX produced 14 S -hydroperoxy-DHA (HpDHA), which was reduced by NaBH 4 to 14 S -HDHA. Chiral LC was used to isolate 14 S -HDHA ( Fig. 1C, middle ) from the incubations, as well as 14 R -HDHA and 14 S -HDHA from racemic 14 S / R -HDHA ( Fig. 1C, bottom) , where the R -hydroxy-DHA (e.g., 14 R -HDHA) has shorter retention time (RT) than its S -hydroxy stereoisomer (14 S -HDHA) ( Fig. 1C , middle and bottom). The order that R -hydroxy compound is eluted before its S -epiomer using this kind chiral LC also fi ts to other hydroxy DHA (data not shown), except 21-H-DHA which seems not to be separable. It also fi ts to hydroxy eicosatetraenoic acids ( 24 ) . Additionally, PGF 2 ␣ (with 15 S -hydroxy) is reported eluted after 15 R -hydroxy PGF 2 ␣ ( 29 ). P450 hydroxylated 14 S -HDHA to two 14 S ,21-diHDHAs which were separated by the chiral LC ( Fig. 1B , upper middle). The C 14 chiral confi guration and doublebond geometry of 14-HDHA are expected to be conserved when 14-HDHA is converted by P450 to 14,21-diHDHAs based on the established knowledge that -1-oxidation does not change the chirality and double-bond confi gurations on other carbon positions of eicosanoid substrates ( 30, 31 ) . Therefore the confi gurations ( R and S ) of asymmetric C 21 in 14 S ,21-diHDHAs are responsible for two isomers observed ( Fig. 1B , upper middle), which were assigned as 14 S ,21 R -diHDHA and 14 S ,21 S -diHDHA for the chiral LC peaks from left to right. For similar reasons, two 14 R ,21-diHDHAs generated from 14 R -HDHA by h-P450 are 14 R ,21 R -diHDHA and 14 R ,21 S -diHDHA which are separated as two chiral LC peaks from left to right ( Fig.1B , lower middle). LC peak areas of 14 R ,21 R -, and 14 R -HDHA were prepared from racemic 14 S/R -HDHAs (Cayman) using the same chiral LC-UV-MS/MS conditions. 14 S ,21-diHDHAs, 14 R ,21-diHDHAs, and 14 S / R ,21-diHDHAs were prepared by incubation of 14 S -HDHA, 14 R -HDHA, and 14 S / R -HDHAs (10 µg/each), respectively, with a human cytochrome P450 (h-P450) enzyme mixture (BioCatalytics Inc., Pasadena, CA) (30°C, 12 h). The h-P450 mixture contained NADPH cofactor, buffer salts, and 1 nmol of seven h-P450 in fi xed ratios (recombinant human CYP1A2, 2C8, 2C9, 2D6, 2E1, and 3A4). One of the objectives for this paper was to determine if any P450 could participate in 14,21-diHDHA formation from DHA as well as intermediates 21-HDHA, 14 S -HDHA, and 14 R -HDHA. However, determining exactly which P450s are responsible for 14,21-diHDHA formation was beyond the scope of this paper. Therefore, we used a mixture of P450s.
Biosynthesis of -1-hydroxy docosanoids and intermediates by Mfs
Thioglycollate-induced Mfs were collected by lavage from murine peritoneal cavity (peritoneal exudate cells, PECs) 3 days after injecting 2.5 ml of 4% thioglucoate (i.p.) as in ( 25 ) . PECs were washed and cultured (24 h, 37°C, 5% CO 2 ) in RPMI1640 containing 10% FBS and other components ( 25 ) . Plates were washed three times with culture medium to remove nonadherent cells. Then adherent cells were harvested, of which more than 90% were F4/80 + .
To generate 14 S ,21-diHDHAs, 14 R ,21-diHDHAs, and/or their deuterated isotopomers, Mfs purifi ed above (5 × 10 6 cells) were cultured in PBS containing DHA, 14 S -HDHA, 14 R -HDHA, or DHA-d 5 (1 M) for 20 min, then stimulated at 37°C for 1 h with TNF-␣ (10 ng/ml), IL-1 ␤ (10 ng/ml), and LPS (100 ng/ ml). DHA in full thickness murine skin wounds can reach as high as 1-9 µmol/kg level (data not shown). Thus 1 M of docosanoic substrate is within concentration range in physiopathological condition of skin. Stimulation with TNF-␣ and IL-1 ␤ mimics the environment of tissue injury, while LPS treatment resembles infection potential during wound healing ( 26 ) . Adding TNF-␣ , IL-1 ␤ , and LPS to macrophages promotes the expression of phospholipase A2 that releases polyunsaturated fatty acids from membranes and/or other parts of the cells; it is also likely to enhance 12/15 lipoxygenase-like activity ( 26 ) that results in 14-hydroxylation of DHA and some DHA derivatives ( 27 ) . The cells and medium from each culture were extracted for the analysis and preparation as described in "LC-UV-MS/MS analysis of docosanoids" for 14,21-diHDHAs or their biosynthetic intermediates.
Statistical analysis
Results were reported as mean ± SEM and analyzed with 2-way ANOVA with a posthoc test. Accepted level of signifi cance for all tests was p < 0.05.
RESULTS
Wounding prompts formation of novel endogenous 14,21-diHDHAs
Three peaks (I, II, and III) of novel DHA-derived 14,21-dihydroxy-docosa-4 Z ,7 Z ,10 Z ,12 E ,16 Z ,19 Z -hexaenoic acids were found using chiral LC-UV-wideband activation MS/ MS analysis of wounded skin tissues from mice after splinted excisional wounding. They were much less in unwounded skin tissues, indicating wounding induced their formation ( Fig. 1A and 1B, top ) . The chiral LC-MS/MS ( Fig. 2C ) . Each MS/MS spectrum matches that of the same 14,21-diHDHA stereoisomer generated by h-P450 ( Fig. 1B ) . The corresponding UV spectra also matched to each other with max of 235-236 nm representing a pair of conjugated double-bonds in each 14,21-diHDHA stereoisomer (insets of Fig. 2A, B ) .
The wideband activation generated MS/MS spectra of 14,21-diHDHA stereoisomers have nearly identical MS/MS ions. However the relative abundances for some of their MS/MS ions are quite different ( Fig. 2A, B ) . For example, ion m/z 253 from MS/MS 359 of 14 R ,21 S -diHDHA and 14 S ,21 S -diHDHA has lower relative abundance than that of 14 R ,21 R -diHDHA and 14 S ,21 R -diHDHA. This is refl ected in the selective ion chromatograms of m/z 253 from MS/ MS at m/z 359. These chromatograms were so insensitive to 14 R ,21 S -diHDHA and 14 S ,21 S -diHDHA that we were not able to show these two stereoismers generated from the incubation [14 S -HDHA + P450] and [14 R -HDHA + P450], respectively (data not shown). However, the relative abundances of ion m/z 271 from MS/MS at m/z 359 ( Fig. 2A, B ) are different from these of m/z 253. We used wideband activation MS/MS and observed four 14,21-diHDHA stereoisomers with selective ion chromatograms of m/z 271 from MS/MS at m/z 359 ( Fig. 1B ) . We saw all four 14,21-diHDHA stereoisomers because selective ion chromatograms of m/z 271 from MS/MS at m/z 359 are sensitive enough to reveal the present of 14 R ,21 S -diHDHA and 14 S ,21 S -diHDHA ( Fig. 1B ) .
14 R ,21 S -diHDHA coelutes with 14 S ,21 R -diHDHA ( Fig. 1B , upper and lower middle; Fig. 2A, B ) under the chiral LC. It is implicated that the abundance ratio of m/z 253/271 is <1 in 14 R ,21 S -diHDHA MS/MS spectrum ( Fig. 2A, right) and is >1 in 14 S ,21 R -diHDHA MS/MS spectrum ( Fig. 2B, middle) . This ratio may provide semiqualitative information to fi nd if a 14,21-diHDHA peak at this RT is mainly 14 R ,21 S -or 14 S ,21 R -diHDHA although the accurate quantifi cation will need the LC separation of these two stereoisomers. At this stage 14 R ,21 S -or 14 S ,21 R -diHDHA is still not separable by LC. Additionally mono-hydroxy DHAs generated by Mfs from DHA are mainly 14 S -HDHA, as well as 14 R -HDHA and 21-HDHA in much less amounts ( Fig. 2C, ( Fig. 1B, bottom) , suggesting that 14 R -HDHA is better substrate than 14 S -HDHA to be converted by the h-P450 to 14,21-diHDHAs.
Peaks I, II, III acquired from wound skin were identifi ed as 14 R ,21 R -diHDHA, 14 S ,21 R -diHDHA/14 R ,21 SdiHDHA, and 14 S ,21 S -diHDHA, respectively, because each of their chiral LC-UV-MS/MS spectra and chromatographic RTs matches to that of the counterpart generated from enzyme incubations ( Fig. 1A, B ). 14 S ,21 R -diHDHA had just slightly longer RT than 14 R ,21 S -diHDHA ( Fig.  1B, upper and lower middle), they were not distinguishable by chiral LC RT. The main mono-hydroxy-DHA in wounds was found to be 14 S -HDHA, the precursor of 14 S ,21-diHDHAs, of which the chiral LC-UV-MS/MS spectrum matches that of 14-HDHA ( 32 ) , and the chiral LC retention time ( Fig. 1C, top) matches that of 14 S -HDHA obtained from incubation of DHA with L-12-LOX ( Fig. 1C,  middle) or from racemic 14 S / R -HDHA standard ( Fig. 1C,  bottom) . 14 R -HDHA in wounds was much less than 14 S -HDHA. The formation of 14 S -HDHA was induced by wounding because the chiral LC peak of 14 S -HDHA in wounds was much higher than that from the nonwounding control ( Fig. 1C, top) . This is consistent with studies showing that 12-LOX activity transforms DHA to 14 S -HDHA (33) (34) (35) . The approximate ratio of 14,21-diHDHA to 14-HDHA in wounds is about 1:7 based on the LC-MS peak areas in selective ion chromatograms at m/z 359 and m/z 343, respectively. The strong UV background from samples in the LC-UV-MS/MS analysis made it impossible to calculate the relative ratio from the absorbance at ‫ف‬ 235 nm. 21-HDHA reported in 1984 ( 36 ) was also found in wounds ( Fig. 1D ) 
Biosynthesis of 14,21-diHDHAs and their intermediates by macrophages
We studied 14,21-diHDHA biosynthesized by Mfs through comparison with 14,21-diHDHAs generated by h-P450 using LC-UV-MS/MS analysis. After stimulation with TNF-␣ , IL-1 ␤ , and LPS, Mfs converted 14 R -HDHA to 14 R ,21 R -diHDHA and 14 R ,21 S -diHDHA ( Fig. 2A ); 14 S - ( Fig. 2D ) . Similar to the approaches for 14,21-diHDHA stereoisomers, we used selective ion chromatograms of m/z 271 from MS/MS at m/z 363 that 14 R ,21-diHDHA. 14 S ,21-diHDHA (50 ng/wound) significantly increased granulation tissue area (by >65%) ( Fig.  3B, left) and reduced epithelial gaps (by >30%) ( Fig. 3B,  right) which was determined by hematoxylin-eosin staining of cryosections at the widest wound beds and microscopic analysis (18) (19) (20) . Immunohistological staining of wound skin cryosections for endothelial protein CD31 showed increased capillary vasculature (by >80%) in 14 S ,21-diHDHA treated wounds at day 4 postwounding compared with vehicle (PBS)-treated wounds ( Fig. 3C ) . ( Fig. 2D ) . Their LC-UV-MS/MS spectra and RTs are consistent with those of corresponding 14,21-diHDHA stereoisomers from wounds ( Fig. 1A  and 1B, top) , h-P450 incubation ( Fig. 1B, middle and bottom), or macrophage incubation ( Fig. 2A-C ) ; and are in support of the structure elucidation. One deuterium at C 21 was replaced by 21-hydroxyl and the other 4 deuterium atoms remained, rendering the molecular ion of 14 ,21-diHDHA-d 4 to be m/z 363 ( Fig. 2D, lower) Peak VIII ( Fig. 2D , upper left and lower middle) is very likely to be mainly 14 S ,21 R -diHDHA-d 4 because its RT ( Fig. 2D, upper left) , MS/MS and UV spectra, and abundance ratio (>1) of m/z 253/271 in MS/MS spectrum ( Fig. 2D, lower middle) is comparable to that for 14 S ,21 RdiHDHA ( Fig. 2B, left and middle) . The LC separation of 14 R ,21 S -diHDHA-d 4 and 14 S ,21 R -diHDHA-d 4 is needed to quantitatively determine the exact composition of peak VIII. In parallel, LC peak II and V of 14,21-diHDHA from wounds ( Fig. 1A, B ) and [DHA + Mf] ( Fig. 2C, left) , respectively, is also likely to be mainly 14 S ,21 R -diHDHA for the similar reason, and the LC separation of 14 R ,21 S -diHDHA and 14 S ,21 R -diHDHA should allow accurate quantifi cation of its composition. Moreover, the mono-hydroxy DHAs-d 5 are 14 S -HDHA-d 5 (major) with minor amounts of 14 R -HDHA-d 5 and 21-HDHA-d 4 ( Fig. 2D , upper middle and right), similar to the profi le of mono-hydroxy DHAs generated by Mfs from DHA ( Fig. 2C ).
14,21-dihydroxy docosahexaenoic acids promote wound healing
The actions of 14 S ,21-diHDHA and 14 R ,21-diHDHA in wound healing were investigated using murine splinted excisional-wound healing model ( Fig. 3 ) . When administrated to wounds, 14 R ,21-diHDHA (14 R ,21 R -diHDHA:14 R ,21 S -di-HDHA 10:1) or 14 S ,21-diHDHA (14 S ,21 R -diHDHA:14 S ,21 SdiHDHA 2:1) signifi cantly accelerated wound closure at day 7 postwounding ( Fig. 3A ) as showed by the photographs (left) and the quantitative results of wounds (right). 14 R ,21-diHDHA was as effi cient as 14 S ,21-diHDHA in promoting wound closure at this dosage. In comparison with PBS control, granulation tissue deposition was more abundant in wounds treated with either 14 S ,21-diHDHA or The tentative formation pathways for 14 S ,21-diHDHAs and 14 R ,21-diHDHAs are summarized as follows ( Fig. 4 ): 14 S -HpDHA is generated from DHA by 12-LOX and then is reduced to 14 S -HDHA in reductive tissue environment; the 14 S -HDHA is sequentially oxidized by P450 at the -1 position to 14 S ,21 R -diHDHA and 14 S ,21 S -diHDHA, which are similar to the -1 oxidation of eicosanoids catalyzed by P450 or occurred in Mfs ( 39, 40 ) . Although L-12-LOX was used for the enzymatic synthesis of 14 S -HDHA and 14 S ,21-diHDHAs, platelet-12-LOX is likely to have the same function ( 34 ) . However, epidermis-12-LOX and 12 R -LOX are likely to be ineffi cient in the transformation of DHA ( 12 ); P450 produces 14 R -HDHA, 14 S -HDHA, and 21-HDHA; then further converts 14 R -HDHA to 14 R ,21-diHDHA, as well as 21-HDHA to 14 R ,21-diHDHA and 14 S ,21-diHDHA. It was reported that in skin P450 CYP1A1, 2B6/7, 2E1, 3A4/7, and 3A5 were detected at protein level and found to possess catalytic activities ( 41 ) ; and many other P450 were found in skin at mRNA level ( 41 ) . CYP2E1 generates 19-HETE ( 16 ) and exists in skin; therefore, it is likely to participate in the -1 hydroxylation by converting 14-H-DHA to 14,21-diHDHAs in the skin ( 16 ) .
Because 14 S ,21-diHDHA and 14 R ,21-diHDHA are produced in wounds and Mfs that contribute to the healing process , as well as generated from DHA by sequential catalysis of 12-LOX and P450 that are known to contribute to vascularization and wound healing ( 37, 38, 42 ) , we predicted that these endogenous small molecules are part of the effectors promoting wound healing. This was tested using the established splinted excisional wound murine model. 14 S ,21-diHDHA and 14 R ,21-diHDHA accelerate wound closure, granulation tissue formation and reepithelialization (as reduction of epithelial gap) in wounds in vivo at dose of 50 ng/wound ( Fig. 3 ) , which demonstrated their pro-healing properties ( 1 ). The dosage of 14 S ,21-diHDHA and 14 R ,21-diHDHA administered to wounds 14 R ,21-diHDHA potently increased granulation tissue area by >65% ( Fig. 3B, left) , reduced epithelial gap by >90% ( Fig. 3B, right) , and enhanced the capillary vascular density by >80% (as CD31+ cells/microscope fi eld) ( Fig.  3C, right) at dose of 50 ng/wound.
DISCUSSION
Our results show that wounding induced formation of novel 14 S ,21 R -and/or 14 R ,21 S -diHDHA, 14 S ,21 S -diH-DHA, and 14 R ,21 R -diHDHA ( Fig. 1A and 1B, top) . P450 transforms 14 S -HDHA to 14 S ,21 R -diHDHA and 14 S ,21 SdiHDHA ( Fig. 1B, upper middle) , where the 12-LOX is the critical enzyme for the generation of 14 S -HDHA from DHA ( Fig. 1C, middle) . P450 converts DHA to 14 R -HDHA and 14 S -HDHA (data not shown), and further transforms 14 R -HDHA to 14 R ,21 S -diHDHA and 14 R ,21 R -diHDHA ( Fig. 1B, lower middle) . Although 14 R -HDHA is a better substrate than 14 S -HDHA to be transformed to 14,21-diHDHAs by the P450 we used ( Fig. 1B , bottom) , the reactivity of 14 R -HDHA and 14 S -HDHA to be converted to 14,21-diHDHA stereoisomers in wounds need to be further studied because profi le and activities of the P450 that catalyze the conversion are not yet established.
L-12-LOX and P450 exist in Mfs (11) (12) (13) (14) (15) . Consistent with the existence of these enzymes, Mfs produce 14 S ,21 RdiHDHA and 14 S ,21 S -diHDHA ( Fig. 2B ) . Mfs are present in wound sites, participate in wound healing ( 1 ) , and are likely to have 12-LOX and or P450 in wounds to produce 14 S ,21-diHDHAs and 14 R ,21-diHDHAs ( Fig. 4 ) . The exact amount of contribution from Mfs to 14 S/R ,21-diHDHA formation in skin wounds remains to be established and is of interest for future study. However, their contribution is likely to be signifi cant because Mfs surge in wound sites at certain times during the course of wound healing ( 37, 38 ) . Fig. 4 . Formation pathways for 14 S ,21-diHDHA and 14 R ,21-diHDHA. The main pathways are demonstrated or proposed as follows. DHA is converted by 12-LOX to 14 S -hydroperoxy-DHA (14 S -HpDHA), which is reduced to 14 S -HDHA; through cytochrome P450, 14 S -HDHA is further converted to 14 S ,21 R -diHDHA and 14 S ,21 S -diHDHA. Alternatively, DHA is fi rst converted by P450 to 14 S -HDHA, 14 R -HDHA, and 21 S (or R )-HDHA, which are further transformed by P450 to 14 R ,21 R -diHDHA, 14 R ,21 S -diHDHA, 14 S ,21 R -diH-DHA, and 14 S ,21 S -diHDHA. 12-LOX and P450 exist in wounds and Mfs. The double-bond geometries of 14 S (or R )-HDHA is conserved after being converted to 14,21-HDHAs on the basis of our results and reported analogous conditions for eicosanoids; this conservation also applies for the transformation of DHA to 21-HDHA. These pathways may involve novel enzymes in addition to those already recognized for eicosanoid formation.
